Table 1.
CYP1B1 expression in relation to clinicopathological findings
| CYP1B1 staining score | ||||
|---|---|---|---|---|
| Variables | Low (n = 34) | High (n = 62) | P value | |
| Median age (yrs) | 58 | 57 | 0.2264 | |
| Gender | ||||
| male | 24 (70.6 %) | 42 (67.7 %) | 0.7735 | |
| female | 10 (29.4 %) | 20 (32.3 %) | ||
| Histology | ||||
| clear cell | 30 (88.2 %) | 53 (85.5 %) | 0.7063 | |
| non-clear cell | 4 (11.8 %) | 9 (14.5 %) | ||
| Fuhrman grade | 0.0875 | |||
| 1–2 | 21 (61.7 %) | 26 (41.9 %) | ||
| 3–4 | 3 (8.9 %) | 12 (19.4 %) | ||
| unknown | 10 (29.4 %) | 24 (38.7 %) | ||
| Stage | 0.0692 | |||
| I–II | 24 (70.6 %) | 32 (51.6 %) | ||
| III–IV | 1 (2.9 %) | 8 (12.9 %) | ||
| unknown | 9 (26.5 %) | 22 (35.5 %) | ||
| Lymph node metastasis | 0.5085 | |||
| negative | 23 (67.7 %) | 32 (51.6 %) | ||
| positive | 1 (2.9 %) | 3 (4.8 %) | ||
| unknown | 10 (29.4 %) | 27 (43.6 %) | ||
| Systematic metastasis | 0.2180 | |||
| negative | 25 (73.5 %) | 37 (59.7 %) | ||
| positive | 2 (5.9 %) | 8 (12.9 %) | ||
| unknown | 6 (17.6 %) | 17 (27.4 %) | ||